Sample6

You Are Viewing

Company

vision

We are on a mission to revolutionize food safety through science, software and passion. In-shift pathogen diagnostics paired with powerful analytics will help shift food safety from reaction to prevention. We will deliver these tools to food processors, retailers and even consumers.


Pathogen Detection-How it works

manage

+

Management

arrow

Michael Koeris, PH.D.

CEO & Founder
close

Co-inventor of technology in Jim Collins' lab at Boston University
Flagship Ventures, McKinsey & Co. and KPMG Consulting
BS, MS Free University Berlin, PhD Boston University
arrow

Gary Greenberger

Vice President, Sales
close

VP Sales of Vela Systems (acquired by Autodesk 2012)
VP Sales of CTSpace (acquired by Sword 2007)
VP Sales of Constructware (acquired by Autodesk 2006)
VP Sales of CompuCom (owned $850M revenues)
BS Penn State
arrow

Jim Hammel

Vice President, Customer Success and Software
close
Product Support Management, Autodesk
Director, Support Services, Vela Systems (Acquired by Autodesk)
BS, Siena College
arrow

Dan Brownell

Associate Director, Manufacturing
close

Qteros, Inc., Joule Unlimited, Microbia, Inc.
BS, University of Massachusetts at Amherst
arrow

Florence Maounis

Assistant Director, Product Management at Sample6
close

Masters of Science in Chemistry from Boston College


MBA from Athens Greece

arrow

Denise Peters

Controller
close

Prior Financial Experience in privately held or publicly traded companiesthat specialize in Medical Device, Pharmaceutical or Software Industries.

advisors

+

Advisors

arrow

Professor Jim Collins, Ph.D.

Scientific Advisor
close

Chairman of Sample6 Scientific Advisory Board
Co-founder of Sample6

Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT

Member of the Harvard-MIT Health Sciences & Technology Faculty.

Core Founding Faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University

Institute Member of the Broad Institute of MIT and Harvard.

His research group works in synthetic biology and systems biology, with a particular focus on using network biology approaches to study antibiotic action, bacterial defense mechanisms, and the emergence of resistance.

Professor Collins' patented technologies have been licensed by over 25 biotech, pharma and medical devices companies, and he has helped to launch a number of companies, including Sample6 Technologies, Synlogic and EnBiotix.

He has received numerous awards and honors, including a Rhodes Scholarship, a MacArthur "Genius" Award, an NIH Director's Pioneer Award, as well as several teaching awards.

Professor Collins is an elected member of all three national academies - the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine - as well as theAmerican Academy of Arts & Sciences and the National Academy of Inventors.
arrow

David Acheson, M.D.

Advisor
close
Former Chief Medical Officer,
FDA Former Assoc. Commissioner of Foods
MD, Infectious Disease
Associate Professor, Tufts University
arrow

Professor Jef Boeke, Ph.D., D.Sc.

Scientific Advisor
close
Professor of Molecular Biology/Genetics and Director of Biology Center at Johns Hopkins University School of Medicine.
Discovered mechanisms of retrotransposition in yeast and human cells.
Elected to American Academy of Microbiology and American Academy of Arts and Sciences
arrow

Brett Chevalier, Ph.D.

Founder & Scientific Advisor
close
Co-founder and Scientific Advisor to Sample6
Associate with Flagship Ventures
Senior Scientist at the Whitehead Institute and Agilent Technologies
University of Washington, Ph.d
Merck Fellow at MIT
arrow

Will Daniels

Advisor
close
Sr. VP Operations, Earthbound Farm
Responsible for all Food Safety
Organic and Operational issues at largest 100% organic producer in USCreated nation’s most robust produce monitoring program
arrow

Peter Farina, Ph.D.

Scientific Advisor
close
Executive in Residence, Canaan Partners
Senior Vice President of Development at Boehringer Ingelheim Pharmaceuticals
Board member of Connecticut United for Research Excellence (CURE);and advisor to several biotech companies
arrow

Professor Martin Loessner, Ph.D.

Scientific Advisor
close
Professor at the Federal Technical University (ETH) Zurich, Switzerland.
Holds Chair of Food Microbiology, serves as the Study Delegate of Department of Health Science and Technology at ETH Zurich.
arrow

Gale Prince

Advisor
close
Former VP Reg Affairs, The Kroger Company
Past President International Assoc of Food Protection
Known as the “Dean of food recalls”
arrow

Professor Martin Wiedmann, DVM., Ph.D.

Scientific Advisor
close
Professor at Cornell, director of Graduate Studies for Food science and technology.
Published 200+ peer-reviewed publications, given 150+ invited presentations.
Was member of Listeria Outbreak Working Group, which was honored by USDA Secretary’s Award for Superior Service
arrow

Tim Curran

Advisor
close

CEO of Vela Systems (acquired by Autodesk 2012)
CEO of Eleven Technologies (acquired by Trimble 2006)
EVP at I-many (IPO 2000)
BS Case Western Reserve, MBA U of Chicago

bod

+

Board of Directors

arrow

Stephen Bloch, M.D.

close

Chairman of Marinus Pharmaceuticals, Board Director Liquidia, Immunology Partners, Dicom Grid
General Partner, Canaan Partners
MD, University of Rochester
MA, Harvard University
A.B., Dartmouth College
arrow

Guy Broadbent

close

President, Vector Advisors LLC
President & CEO
Xcellerex
Sr. VP
ThermoFisher Scientific
arrow

Sam Kass

VP, Acre Venture Partners
close

Sam Kass is a Food Entrepreneur, Former White House Chef and Senior Policy Advisor for Nutrition. He is the founder of TROVE and a partner in Acre Venture Partners.

Sam joined the White House kitchen staff in 2009 as Assistant Chef and, in 2010, became Food Initiative Coordinator.

During his White House tenure, he took on several additional roles including Executive Director of First Lady Michelle Obama’s “Let’s Move!” campaign and senior White House Policy Advisor for Nutrition.

Sam is the first person in the history of the White House to have a position in the Executive Office of the President and the Residence.

As one of the First Lady’s longest-serving advisors, he served as Senior Policy Advisor for Healthy Food Initiatives and he helped the First Lady create the first major vegetable garden at the White House since Eleanor Roosevelt’s victory garden.

In 2011, Fast Company included Sam in their list of 100 Most Creative People, and in 2012, he helped create the American Chef Corps, which is dedicated to promoting diplomacy through culinary initiatives.

He is also an MIT Media lab fellow, entrepreneur and advisor.
arrow

Michael Koeris, PH.D.

CEO and Founder, Sample6
close

Co-inventor of technology in Jim Collins' lab at Boston University
Flagship Ventures, McKinsey & Co. and KPMG Consulting
BS, MS Free University Berlin, PhD Boston University
arrow

Professor Timothy Lu

close

Co-inventor of technology in Jim Collin's lab at Boston University
2010 TechReview “35 under 35”
MIT Lemelson Prize Winner
SB, MEng, PhD MIT
MD Harvard Medical School

investors

+

Investors

arrow

Canaan Partners

close
Canaan Partners is a global venture capital firm that invests in people who turn visionary ideas into valuable and significant technology & healthcare companies. We were early investors in some of the world’s leading technology companies, including Acme Packet, CommerceOne, and DoubleClick as well as healthcare giants Cerexa, Dexcom and Peninsula Pharmaceuticals.
arrow

Acre Venture Partners

close
Acre Venture Partners focuses on funding innovators in the global food supply chain to improve accessibility, affordability and sustainability of food production worldwide
arrow

Cultivian Sandbox

close
Cultivian Sandbox is a venture capital firm focused on building next-generation disruptive food and agriculture technology companies. Much more than a financial resource, they are capable of delivering value though active collaboration with their strategic partners and network, which are unparalleled in their industries of focus. Their expertise in sourcing, evaluating, closing, managing and ultimately exiting successful equity investments positions them to not only build stronger businesses, but reshape industries.
arrow

Valley Oak Investments

Description
close
Valley Oak Investments is a San Francisco-based venture capital firm that invests in early-stage companies building revolutionary technologies and brands within the food, agriculture, and health & wellness industries. Valley Oak manages a permanent capital base and partners with extraordinary entrepreneurs to build sustainable enterprises of impact.
arrow

Chevron

close
Chevron Technology Ventures (CTV) helps Chevron embrace emerging technologies to create new commercial opportunities, reduce costs and improve performance. CTV serves as one of the company's most important technology scouts, always searching for emerging technologies that could enhance Chevron's strategies. CTV identifies, acquires, tests, validates, and, if appropriate, helps integrate technologies into the company's core businesses.
arrow

Flybridge

close
Flybridge is an early-stage venture capital firm. Their goal is to find talented entrepreneurs and then partner with them to build exceptional and valuable companies. Flybridge focuses on providing guidance and perspective in a complimentary way to the entrepreneurs we invest in and help them build connections to soar to the next level.
arrow

Founder Collective

close
Founder Collective is a seed-stage venture capital fund, built by a collection of successful entrepreneurs. They are headquartered in New York City and Cambridge, but make investments all over the world.
arrow

The Kraft Group

close
Over the years The Kraft Group has grown its portfolio to include investments across many industries and business types. It has combined the Kraft family's entrepreneurial experience with a talented team of professionals made up of financial advisors, legal counsel and tax experts - all trusted, long-standing members of The Kraft Group.

ourhistory

Our History

Our Name

We named our company Sample6 because it combined the challenge of pathogen control and our solution.  The challenge in pathogen control is quickly and effectively processing samples.  When the Bioillumination Platform™ is applied to samples, we convert pathogens into light.  During our initial experiments, we were able to detect as few as 6 cells without enrichment. We quickly achieved single cell detection, but 6 has remained a lucky number for us. We are Sample6. Together, we can make food safer.

Our Founders

Sample6’s core technology was originally developed and conceived in Dr. James Collins’ lab at Boston University. Tim Lu, Michael Koeris and Tanguy Chau, who were then Ph.D. students at BU and MIT, first founded the Company in March 2009 under the name Novophage Therapeutics, Inc. Through a number of successes in business plan competitions, Lu, Koeris and Chau jointly developed and explored a variety of applications for the technology, including using bacteriophages as a therapeutic treatment for bacterial infections. From these early seeds eventually grew what is now Sample6.